Treatment of hemiplegic migraine with triptans.
Eur J Neurol
; 14(9): 1053-6, 2007 Sep.
Article
em En
| MEDLINE
| ID: mdl-17718700
ABSTRACT
The objective of this study was to investigate the efficacy, safety and tolerability of triptans in patients who suffer from familial or sporadic hemiplegic migraine. Seventy-six subjects had used triptans at least once as an abortive treatment. Average triptan response was 6.9 (SD +/-3.1) and adverse event severity 4.9 (SD +/-3.3) on a scale from 0 to 10 (no response or side effect 0, excellent response or unbearable side effects 10). None of the patients had an ischaemic stroke or a heart attack. One patient reported prolonged neurological symptoms, related to a single dose of rizatriptan, but there were no pathological findings in several MRI-scans. Triptans seem to be safe and effective treatment for most hemiplegic migraine patients.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Triptaminas
/
Agonistas do Receptor de Serotonina
/
Enxaqueca com Aura
Tipo de estudo:
Evaluation_studies
Limite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2007
Tipo de documento:
Article